Manufacturer
MALAYSIAN PHARMACEUTICAL INDUSTRIES SDN. BHD.
Contents
Sulpiride
Indication
Schizophrenia.
Instruction
May be taken with or without food.
Drug interaction
Combination w/ bradycardia-inducing medications (e.g. β-blockers, some Ca channel blockers) or medications which induce electrolyte imbalance (e.g. hypokalaemic diuretics, stimulant laxatives, IV amphotericin B, glucocorticoids, tetracosactides) may induce torsades de pointes or prolong the QT interval. Enhanced postural hypotension if used w/ other antihypertensive drugs. Concurrent use w/ other CNS depressants may cause increased CNS depression. Co-admin w/ antacids or sucralfate may decrease sulpiride absorption. Concurrent use w/ lithium increases the risk of extrapyramidal side effects. May reduce effectiveness of ropinorole.Potentially Fatal: Reciprocal antagonism of effects between levodopa and neuroleptics.
Malaysia
